Tracer uptake in mediastinal and paraaortal thoracic lymph nodes as a potential pitfall in image interpretation of PSMA ligand PET/CT

PurposeSince the introduction of 68Ga-PSMA-11 PET/CT for imaging prostate cancer (PC) we have frequently observed mediastinal lymph nodes (LN) showing tracer uptake despite being classified as benign. The aim of this evaluation was to further analyze such LN.MethodsTwo patient groups with biphasic 6...

Full description

Saved in:
Bibliographic Details
Main Authors: Afshar-Oromieh, Ali (Author) , Holland-Letz, Tim (Author) , Mier, Walter (Author) , Kiß, Oliver (Author) , Kopka, Klaus (Author) , Haberkorn, Uwe (Author) , Sattler, Lars Peter (Author) , Weichert, Wilko (Author)
Format: Article (Journal)
Language:English
Published: 1 March 2018
In: European journal of nuclear medicine and molecular imaging
Year: 2018, Volume: 45, Issue: 7, Pages: 1179-1187
ISSN:1619-7089
DOI:10.1007/s00259-018-3965-8
Online Access:Verlag, Volltext: https://doi.org/10.1007/s00259-018-3965-8
Verlag, Volltext: https://link.springer.com/content/pdf/10.1007%2Fs00259-018-3965-8.pdf
Get full text
Author Notes:Ali Afshar-Oromieh, Lars Peter Sattler, Katja Steiger, Tim Holland-Letz, Marcelo Livorsi da Cunha, Walter Mier, Oliver Neels, Klaus Kopka, Wilko Weichert, Uwe Haberkorn
Description
Summary:PurposeSince the introduction of 68Ga-PSMA-11 PET/CT for imaging prostate cancer (PC) we have frequently observed mediastinal lymph nodes (LN) showing tracer uptake despite being classified as benign. The aim of this evaluation was to further analyze such LN.MethodsTwo patient groups with biphasic 68Ga-PSMA-11 PET/CT at 1 h and 3 h p.i. were included in this retrospective evaluation. Group A (n = 38) included patients without LN metastases, and group B (n = 43) patients with LN metastases of PC. SUV of mediastinal/paraaortal LN of group A (n = 100) were compared to SUV of LN metastases of group B (n = 91). Additionally, 22 randomly selected mediastinal and paraaortal LN of patients without PC were immunohistochemically (IHC) analyzed for PSMA expression.ResultsIn group A, 7/38 patients (18.4%) presented with at least one PSMA-positive mediastinal LN at 1 h p.i. and 3/38 (7.9%) positive LN at 3 h p.i. with a SUVmax of 2.3 ± 0.7 at 1 h p.i. (2.0 ± 0.7 at 3 h p.i.). A total of 11 PSMA-positive mediastinal/paraaortal LN were detected in nine patients considering both imaging timing points. SUVmax of LN-metastases was 12.5 ± 13.2 at 1 h p.i. (15.8 ± 17.0 at 3 h p.i.). SUVmax increased clearly (> 10%) between 1 h and 3 h p.i. in 76.9% of the LN metastases, and decreased significantly in 72.7% of the mediastinal/paraaortal LN. By IHC, PSMA-expression was observed in intranodal vascular endothelia of all investigated LN groups and to differing degrees within germinal centers of 15/22 of them (68.1%). Expression was stronger in mediastinal nodes (p = 0.038) and when follicular hyperplasia was present (p = 0.050).ConclusionPSMA-positive mediastinal/paraaortal benign LN were visible in a notable proportion of patients. PSMA-positivity on the histopathological level was associated with the activation state of the LN. However, in contrast to LN metastases of PC, they presented with significantly lower uptake, which, in addition, usually decreased over time.
Item Description:Gesehen am 10.05.2019
Physical Description:Online Resource
ISSN:1619-7089
DOI:10.1007/s00259-018-3965-8